SPY329.07+0.28 0.09%
DIA267.73+1.01 0.38%
IXIC10,891.06-11.74 -0.11%

BMO Capital Maintains Outperform on Amgen, Raises Price Target to $275

BMO Capital maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $240 to $275.

Benzinga · -

BMO Capital maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $240 to $275.